Audio from the Dec. 10-12 press teleconferences is now available.
Levels of Cancer-causing Chemicals in Smokeless Tobacco Products Influence Carcinogen Exposure
Researchers to Present Progression-free Survival Results
Multigene Test Can Predict Risk of Disease Recurrence for Women With Ductal Carcinoma in Situ
Lowering Dietary Fat Intake Reduces Death Rates in Some Women With Breast Cancer
AACR Annual Meeting 2015, April 18-22, 2015
Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment of certain patients with acute lymphoblastic leukemia (ALL).